Experimental rectal cancer drug caused tumors to disappear in all patients in small trials

In an unprecedented clinical study, a dozen rectal cancer patients saw their tumors disappear after receiving an experimental drug called dostarlimab, and none of the patients experienced significant side effects from the treatment.

“I believe this is the first time in the history of Cancer“As this is the first cancer study in which every patient went into remission, Dr. Luis Alberto Diaz, Jr., co-investigator and medical oncologist at Memorial Sloan Kettering (MSK) Cancer Center, said the New York Times (opens in new tab).

Leave a Reply

Your email address will not be published.